Mark Painter

Mark Painter is CEO of PRS Urology SC in Denver.

Articles

Breaking down the CMS 2023 final rule for urologists

November 30, 2022

"We once again note that even success in the efforts to avoid any payment decreases will be a failure in the long run as overhead continues to rise against flat reimbursement," write Jonathan Rubenstein, MD, and Mark Painter.

How to get reimbursed for multiplex PCR urine cultures

November 08, 2022

"Although Medicare has developed previous coverage directives for several types of PCR tests outside of UTI detection and there are sound arguments for the use of PCR tests in detecting UTIs, Medicare only recently published a local coverage determination that included the use of PCR tests for UTI detection," write Jonathan Rubenstein, MD, and Mark Painter.

Why can’t CPT 50436 and 50437 be used when performing percutaneous nephrolithotomy?

October 14, 2022

"For several reasons, the percutaneous nephrolithotomy codes needed to be revised, as the language of the descriptor and what was included and not included was confusing and ambiguous," write Jonathan Rubenstein, MD, and Mark Painter.